The Elite Research Network identifies clinical study opportunities by connecting our investigators with sponsors and contract research organizations. The group, comprised of independently owned, multi-specialty sites located throughout the United States, conducts clinical studies across a broad range of therapeutic areas in all clinical phases. By locating appropriate studies that match our sites' capabilities and patient populations, our sites consistently meet or exceed enrollment goals. There is no additional cost to our clients
and all contracts and study related payments are directly with the investigator sites.

Sites within the network must meet and maintain certain entrance criteria. Each site has a dedicated research staff consisting of highly trained, board certified investigators, study coordinators, patient recruiters, and support staff. Sites have EDC capabilities, use central IRBs with start-up regulatory document turnaround time within 5 days or less, and are in full compliance with FDA, GCP, ICH, and IRB guidelines.

Serving as a central point of contact for the network saves our clients time and resources by streamlining information to our sites in order to make informed decisions about which studies are most appropriate. This allows site identification, feasibility, and study start up to occur at an accelerated pace.

Because each study is different, we allow our clients to maintain strategic control of the site selection process. Once investigators from the network have been rapidly identified and prequalified to conduct a study in a certain indication, clients are given the flexibility to use as few or as many sites as needed. Study start up documents such as confidentiality agreements, questionnaires, and a synopsis can be sent either to the central office to distribute to the appropriate sites or directly to each site.